Description: Amunix is an immuno-oncology company leveraging Pro-XTEN technology platform to discover and develop transformative therapies for patients with cancer.
“Tell me, what is it you plan to do with your one wild and precious life?”
– Mary Oliver
Sanofi Announces Completion of Amunix Acquisition & Amunix Combines Forces with Sanofi’s Team